title: Advances in the management of basal cell carcinoma.
abstract: Basal cell carcinoma (BCC), a malignant neoplasm derived from non-keratinizing cells that originate in the basal layer of the epidermis, is the most common cancer in humans. Several factors such as anatomic location, histologic features, primary or recurrent tumors, and patient characteristics influence the choice of treatment modality for BCC. Mohs micrographic surgery (MMS) facilitates optimal margin control and conservation of normal tissue for the management of BCC; however, other treatment modalities may also be implemented in the correct clinical scenario. Other treatment modalities that will be reviewed include simple excision, electrodesiccation and curettage, cryotherapy, topical immunotherapy and chemotherapy, photodynamic therapy, and radiation therapy. In addition, targeted molecular therapeutic options for the treatment of advanced or metastatic BCC will be discussed in this informal review based on recent literature obtained by using PubMed with relevant search terms.
authors.affiliation: 240 East 38 Street, 12 Floor, New York, NY 10016; USA.
authors.forename: Jesse M
authors.initials: JM
authors.lastname: Lewin
authors.affiliation: 240 East 38 Street, 12 Floor, New York, NY 10016; USA.
authors.forename: John A
authors.initials: JA
authors.lastname: Carucci